Affordable Access

deepdyve-link
Publisher Website

[Adult T cell leukemia-lymphoma with allo-HSCT after treatment for pulmonary involvement with Mogamulizumab].

Authors
  • Kawashima, Ichiro
  • Sueki, Yuki
  • Yamamoto, Takeo
  • Nozaki, Yumi
  • Nakajima, Kei
  • Mitsumori, Toru
  • Kirito, Keita
Type
Published Article
Journal
[Rinshō ketsueki] The Japanese journal of clinical hematology
Publication Date
Feb 01, 2015
Volume
56
Issue
2
Pages
210–215
Identifiers
DOI: 10.11406/rinketsu.56.210
PMID: 25765802
Source
Medline
License
Unknown

Abstract

Adult T cell lymphoma-leukemia (ATL) is a highly aggressive disease and allogeneic hematopoietic transplantation (allo-HSCT) is the only therapeutic option for achieving a cure. However, some ATL patients cannot undergo HSCT. One of the important reasons for restricting HSCT in ATL is the high incidence of pulmonary complications associated with ATL including opportunistic infections, infiltration of ATL cells, and HTLV-1 associated bronchopneumonopathy. Herein, we report an ATL case with pulmonary infiltration of ATL cells successfully treated with allo-HSCT after improvement of pulmonary function with administration of the anti-CCR4 antibody mogamulizumab. To our knowledge, this is the first ATL case showing improvement of pulmonary invasion of ATL cells after treatment with mogamulizumab. In addition, this case suggests that mogamulizumab treatment might be useful as a bridge to allo-HSCT in ATL patients.

Report this publication

Statistics

Seen <100 times